These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 37819546)
21. Validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: extra-cranial disease progression is an independent risk factor. Zhuang Q; Wong RX; Lian WX; Li YQ; Wong FY Ann Palliat Med; 2019 Sep; 8(4):390-400. PubMed ID: 30943738 [TBL] [Abstract][Full Text] [Related]
22. Cumulative Intracranial Tumor Volume (CITV) Enhances the Prognostic Value of the Lung-Specific Graded Prognostic Assessment (GPA) Model. Marcus LP; Marshall D; Hirshman BR; McCutcheon BA; Gonda DD; Koiso T; Hattangadi-Gluth JA; Carter BS; Yamamoto M; Chen CC Neurosurgery; 2016 Aug; 79(2):246-52. PubMed ID: 26579964 [TBL] [Abstract][Full Text] [Related]
24. Upfront stereotactic radiosurgery in patients with brain metastases from small cell lung cancer: retrospective analysis of 41 patients. Yomo S; Hayashi M Radiat Oncol; 2014 Jul; 9():152. PubMed ID: 25005424 [TBL] [Abstract][Full Text] [Related]
25. External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience. Griguolo G; Jacot W; Kantelhardt E; Dieci MV; Bourgier C; Thomssen C; Bailleux C; Miglietta F; Braccini AL; Conte P; Ferrero JM; Guarneri V; Darlix A Breast; 2018 Feb; 37():36-41. PubMed ID: 29073498 [TBL] [Abstract][Full Text] [Related]
26. Long-term survival in patients with brain metastases-clinical characterization of a rare scenario. Hügel M; Stöhr J; Kuhnt T; Nägler F; Papsdorf K; Klagges S; Hambsch P; Güresir E; Nicolay NH; Seidel C Strahlenther Onkol; 2024 Apr; 200(4):335-345. PubMed ID: 37646818 [TBL] [Abstract][Full Text] [Related]
27. Use of the Graded Prognostic Assessment (GPA) score in patients with brain metastases from primary tumours not represented in the diagnosis-specific GPA studies. Nieder C; Andratschke NH; Geinitz H; Grosu AL Strahlenther Onkol; 2012 Aug; 188(8):692-5. PubMed ID: 22526229 [TBL] [Abstract][Full Text] [Related]
28. Improving the Prognostic Value of Disease-Specific Graded Prognostic Assessment Model for Renal Cell Carcinoma by Incorporation of Cumulative Intracranial Tumor Volume. Ali MA; Hirshman BR; Wilson B; Schupper AJ; Joshi R; Proudfoot JA; Goetsch SJ; Alksne JF; Ott K; Aiyama H; Nagano O; Carter BS; Chiang V; Serizawa T; Yamamoto M; Chen CC World Neurosurg; 2017 Dec; 108():151-156. PubMed ID: 28754641 [TBL] [Abstract][Full Text] [Related]
29. External Validation of a Prognostic Score for Patients with Brain Metastases: Extended Diagnosis-Specific Graded Prognostic Assessment. Nieder C; Hess S; Lewitzki V Oncol Res Treat; 2020; 43(5):221-227. PubMed ID: 32213772 [TBL] [Abstract][Full Text] [Related]
30. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors. Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409 [TBL] [Abstract][Full Text] [Related]
31. Validation of the Disease-Specific GPA for Patients With 1 to 3 Synchronous Brain Metastases in Newly Diagnosed NSCLC. Woody NM; Greer MD; Reddy CA; Videtic GMM; Chao ST; Murphy ES; Suh JH; Angelov L; Barnett GH; Vogelbaum MA; Stephans KL Clin Lung Cancer; 2018 Jan; 19(1):e141-e147. PubMed ID: 28739316 [TBL] [Abstract][Full Text] [Related]
32. Robustness of the neurological prognostic score in brain metastasis patients treated with Gamma Knife radiosurgery. Serizawa T; Higuchi Y; Nagano O; Matsuda S; Aoyagi K; Ono J; Saeki N; Iwadate Y; Hirai T; Takemoto S; Shibamoto Y J Neurosurg; 2017 Nov; 127(5):1000-1006. PubMed ID: 27911235 [TBL] [Abstract][Full Text] [Related]
33. Comparing survival predicted by the diagnosis-specific Graded Prognostic Assessment (DS-GPA) to actual survival in patients with 1-10 brain metastases treated with stereotactic radiosurgery. Nagtegaal SHJ; Claes A; Suijkerbuijk KPM; Schramel FMNH; Snijders TJ; Verhoeff JJC Radiother Oncol; 2019 Sep; 138():173-179. PubMed ID: 31302392 [TBL] [Abstract][Full Text] [Related]
34. Prognostic Importance of Cumulative Intracranial Tumor Volume in Patients with Gastrointestinal Brain Metastasis Treated with Stereotactic Radiosurgery. Joshi RS; Hirshman BR; Ali MA; Alattar A; Carroll K; Nagano O; Aiyama H; Serizawa T; Yamamoto M; Chen CC World Neurosurg; 2019 Jan; 121():e747-e754. PubMed ID: 30308343 [TBL] [Abstract][Full Text] [Related]
35. A new grading system focusing on neurological outcomes for brain metastases treated with stereotactic radiosurgery: the modified Basic Score for Brain Metastases. Serizawa T; Higuchi Y; Nagano O; Matsuda S; Ono J; Saeki N; Hirai T; Miyakawa A; Shibamoto Y J Neurosurg; 2014 Dec; 121 Suppl():35-43. PubMed ID: 25434935 [TBL] [Abstract][Full Text] [Related]
36. Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic Factors. Sperduto PW; De B; Li J; Carpenter D; Kirkpatrick J; Milligan M; Shih HA; Kutuk T; Kotecha R; Higaki H; Otsuka M; Aoyama H; Bourgoin M; Roberge D; Dajani S; Sachdev S; Gainey J; Buatti JM; Breen W; Brown PD; Ni L; Braunstein S; Gallitto M; Wang TJC; Shanley R; Lou E; Shiao J; Gaspar LE; Tanabe S; Nakano T; An Y; Chiang V; Zeng L; Soliman H; Elhalawani H; Cagney D; Thomas E; Boggs DH; Ahluwalia MS; Mehta MP Int J Radiat Oncol Biol Phys; 2022 Sep; 114(1):60-74. PubMed ID: 35331827 [TBL] [Abstract][Full Text] [Related]
38. Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgery. Bian SX; Routman D; Liu J; Yang D; Groshen S; Zada G; Trakul N; Wong MK; Yu C; Chang EL J Neurosurg; 2016 Dec; 125(Suppl 1):31-39. PubMed ID: 27903181 [TBL] [Abstract][Full Text] [Related]
39. [Radiotherapy of brain metastases according to the GPA score (Graded Prognostic Assessment)]. Antoni D; Noël G Cancer Radiother; 2013 Oct; 17(5-6):424-7. PubMed ID: 23973456 [TBL] [Abstract][Full Text] [Related]
40. Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA). Patrikidou A; Chaigneau L; Isambert N; Kitikidou K; Shanley R; Ray-Coquard I; Valentin T; Malivoir B; Laigre M; Bay JO; Moureau-Zabotto L; Bompas E; Piperno-Neumann S; Penel N; Alcindor T; Guillemet C; Duffaud F; Hügli A; Le Pechoux C; Dhermain F; Blay JY; Sperduto PW; Le Cesne A BMC Cancer; 2020 Feb; 20(1):117. PubMed ID: 32050939 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]